ipilimumab
bms
['rova', 'melanoma', 'ipilimumab']
dr. wolchok's work was instrumental in the clinical development and approval of immune checkpoint inhibitor #ipilimumab in #melanoma, while his broader research and leadership efforts have helped establish msk as a leader in the field of immunotherapy. #asco22
The official account of Memorial Sloan Kettering Cancer Center, the Sloan Kettering Institute, and Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences